Clinical efficacy of focused ultrasound combined with Shenju lotion in the treatment of vulvar intraepithelial non neoplastic lesions

注册号:

Registration number:

ITMCTR2000004033

最近更新日期:

Date of Last Refreshed on:

2020-08-29

注册时间:

Date of Registration:

2020-08-29

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

聚焦超声联合参菊洗剂治疗外阴上皮内非瘤样病变的临床疗效观察

Public title:

Clinical efficacy of focused ultrasound combined with Shenju lotion in the treatment of vulvar intraepithelial non neoplastic lesions

注册题目简写:

English Acronym:

研究课题的正式科学名称:

聚焦超声联合参菊洗剂治疗外阴上皮内非瘤样病变的临床疗效观察

Scientific title:

Clinical efficacy of focused ultrasound combined with Shenju lotion in the treatment of vulvar intraepithelial non neoplastic lesions

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

ChiCTR2000037618 ; ChiMCTR2000004033

申请注册联系人:

王磊

研究负责人:

王磊

Applicant:

Wang Lei

Study leader:

Wang Lei

申请注册联系人电话:

Applicant telephone:

+86 13919862168

研究负责人电话:

Study leader's telephone:

+86 13919862168

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

948629023@qq.com

研究负责人电子邮件:

Study leader's E-mail:

948629023@qq.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

甘肃省兰州市七里河区瓜州路418号

研究负责人通讯地址:

甘肃省兰州市七里河区瓜州路418号

Applicant address:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu

Study leader's address:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

甘肃省中医院

Applicant's institution:

Gansu Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

FJ/04-IRB/C/018-V3.0

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

甘肃省中医院伦理委员会

Name of the ethic committee:

Ethics Committee of Gansu Hospital of Traditional Chinese Medicine

伦理委员会批准日期:

Date of approved by ethic committee:

2020/8/13 0:00:00

伦理委员会联系人:

李玉梅

Contact Name of the ethic committee:

Li Yumei

伦理委员会联系地址:

甘肃省兰州市七里河区瓜州路418号

Contact Address of the ethic committee:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu.

伦理委员会联系人电话:

Contact phone of the ethic committee:

伦理委员会联系人邮箱:

Contact email of the ethic committee:

研究实施负责(组长)单位:

甘肃省中医院

Primary sponsor:

Gansu Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

甘肃省兰州市七里河区瓜州路418号

Primary sponsor's address:

418 Guazhou Road, Qilihe District, Lanzhou, Gansu.

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

甘肃

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省中医院

具体地址:

七里河区瓜州路418号

Institution
hospital:

Gansu Hospital of Traditional Chinese Medicine

Address:

418 Guazhou Road, Qilihe District

经费或物资来源:

自筹

Source(s) of funding:

raise independently

研究疾病:

外阴上皮内非瘤样病变

研究疾病代码:

Target disease:

Intraepithelial neoplasia of vulva

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

研究高强度聚焦超声联合科室协定方参菊洗剂治疗外阴白斑的临床疗效。并通过免疫组化指标分析该方法治疗外阴白斑的作用机理,为我科多年来治疗外阴白斑满意的疗效提供科学的理论依据。

Objectives of Study:

Objective to study the clinical effect of high intensity focused ultrasound combined with Shenju lotion in the treatment of vulva leukoplakia. The mechanism of the treatment of vulvar leukoplakia was analyzed by immunohistochemical index, which provided scientific theoretical basis for the satisfactory effect of treatment of vulva leukoplakia in our department for many years.

药物成份或治疗方案详述:

Description for medicine or protocol of treatment in detail:

纳入标准:

① 符合外阴上皮内非瘤样病变诊断标准,均经外阴活组织病理学检查证实; ② 参与本研究前未接受其他治疗; ③ 患者及家属自愿签署知情同意书。

Inclusion criteria

1. All the patients met the diagnostic criteria of vulvar intraepithelial non neoplastic lesions and were confirmed by vulvar biopsy. 2. Patients did not receive other treatment before participating in this study. 3. Patients and their families voluntarily signed informed consent.

排除标准:

① 月经期、妊娠期及哺乳期; ② 病历记录缺损或不详; ③ 外阴癌、外阴癌前病变、急性外阴或阴道感染; ④ 有全身性疾病或糖尿病。

Exclusion criteria:

1. Menstrual period, pregnancy and lactation period; 2. The medical records are defective or unknown; 3. Vulvar cancer, vulvar precancerous lesions, acute vulvar or vaginal infection; 4. Systemic diseases or diabetes.

研究实施时间:

Study execute time:

From 2020-08-28

To      2022-08-27

征募观察对象时间:

Recruiting time:

From 2020-09-01

To      2021-09-01

干预措施:

Interventions:

组别:

试验组

样本量:

30

Group:

experimental group

Sample size:

干预措施:

聚焦超声联合参菊洗剂治疗

干预措施代码:

Intervention:

Treatment of focused ultrasound combined with Shenju Lotion

Intervention code:

组别:

对照组

样本量:

30

Group:

control group

Sample size:

干预措施:

聚焦超声

干预措施代码:

Intervention:

focused ultrasound

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

甘肃

市(区县):

兰州

Country:

China

Province:

Gansu

City:

Lanzhou

单位(医院):

甘肃省中医院

单位级别:

三级甲等

Institution/hospital:

Gansu Hospital of Traditional Chinese Medicine

Level of the institution:

Tertiary A

测量指标:

Outcomes:

指标中文名:

瘙痒

指标类型:

主要指标

Outcome:

pruritus

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

内皮素-1

指标类型:

主要指标

Outcome:

Endothelin-1

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

血管内皮生长因子

指标类型:

主要指标

Outcome:

vascular endothelial growth factor

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

外阴皮肤

组织:

Sample Name:

Skin of vulva

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

正在进行

Recruiting

年龄范围:

最小 18
Min age years
最大 70
Max age years

Recruiting status:

Participant age:

性别:

Gender:

女性

Female

随机方法(请说明由何人用什么方法产生随机序列):

随机数字表法随机分组

Randomization Procedure (please state who generates the random number sequence and by what method):

Random number table method for random grouping

盲法:

未说明

Blinding:

Not stated

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

试验完成后6个月内公开

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

6 months after the completion of the test

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

研究病历本记录

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

Research medical record

数据管理委员会:

Data Managemen Committee:

Yes

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above